Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.
作者信息
Oldenburg Catherine E, Doan Thuy
机构信息
Department of Ophthalmology, University of California, San Francisco, San Francisco, California.
Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, California.
出版信息
Am J Trop Med Hyg. 2020 Jun;102(6):1154-1155. doi: 10.4269/ajtmh.20-0262.
Abstract
摘要
相似文献
1
Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.
Am J Trop Med Hyg. 2020 Jun;102(6):1154-1155. doi: 10.4269/ajtmh.20-0262.
2
Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings.
Am J Trop Med Hyg. 2020 Jun;102(6):1184-1188. doi: 10.4269/ajtmh.20-0290.
3
Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.01101-20.
4
Biggest COVID-19 trial tests repurposed drugs first.
Nat Biotechnol. 2020 May;38(5):510. doi: 10.1038/s41587-020-0528-x.
5
The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19.
Antimicrob Agents Chemother. 2020 Jul 22;64(8). doi: 10.1128/AAC.01127-20.
6
COVID-19 in the Eastern Mediterranean Region and Saudi Arabia: prevention and therapeutic strategies.
Int J Antimicrob Agents. 2020 May;55(5):105968. doi: 10.1016/j.ijantimicag.2020.105968. Epub 2020 Apr 4.
7
COVID-19: The Need for Immunoprevention at Industrial Scale.
Am J Trop Med Hyg. 2020 Jun;102(6):1151. doi: 10.4269/ajtmh.20-0239.
8
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.
Eur Respir J. 2020 Jul 9;56(1). doi: 10.1183/13993003.01398-2020. Print 2020 Jul.
9
[From empiricism to scientific evidence in antiviral treatment in severe cases of coronavirus infection in times of epidemic].
Med Intensiva (Engl Ed). 2020 Nov;44(8):509-512. doi: 10.1016/j.medin.2020.04.009. Epub 2020 Apr 22.
10
Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab.
Infection. 2020 Oct;48(5):767-771. doi: 10.1007/s15010-020-01476-7. Epub 2020 Jul 8.
引用本文的文献
1
Doxycycline vs Hydroxychloroquine + Azithromycin in the Management of COVID-19 Patients: An Open-Label Randomized Clinical Trial in Sub-Saharan Africa (DOXYCOV).
Cureus. 2023 Sep 20;15(9):e45619. doi: 10.7759/cureus.45619. eCollection 2023 Sep.
2
TEG, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy.
J Clin Med. 2021 Nov 18;10(22):5381. doi: 10.3390/jcm10225381.
3
Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials.
J Infect Public Health. 2021 Jun;14(6):740-748. doi: 10.1016/j.jiph.2021.03.015. Epub 2021 Apr 20.
4
Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review.
Hypertens Res. 2021 Apr;44(4):386-398. doi: 10.1038/s41440-020-00604-y. Epub 2021 Jan 20.
5
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study.
EClinicalMedicine. 2020 Aug;25:100454. doi: 10.1016/j.eclinm.2020.100454. Epub 2020 Jul 10.
本文引用的文献
1
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
2
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
3
The Author's Response: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR.
J Korean Med Sci. 2020 Feb 24;35(7):e89. doi: 10.3346/jkms.2020.35.e89.
4
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial.
Lancet HIV. 2018 Mar;5(3):e116-e125. doi: 10.1016/S2352-3018(17)30205-9. Epub 2017 Nov 30.
5
A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response.
Clin Trials. 2016 Feb;13(1):22-30. doi: 10.1177/1740774515621721. Epub 2016 Jan 14.
Zotero 插件